Geneos Wealth Management’s First Trust Financials AlphaDEX Fund FXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Sell
14,711
-1,320
-8% -$78.6K 0.02% 565
2026
Q1
$901K Buy
16,031
+2,107
+15% +$125K 0.02% 533
2025
Q4
$840K Buy
13,924
+11
+0.1% +$647 0.02% 547
2025
Q3
$826K Buy
13,913
+3,163
+29% +$184K 0.02% 532
2025
Q2
$603K Buy
10,750
+1,151
+12% +$60.3K 0.01% 657
2025
Q1
$509K Buy
9,599
+243
+3% +$13.3K 0.02% 614
2024
Q4
$506K Buy
9,356
+3,778
+68% +$207K 0.02% 585
2024
Q3
$285K Hold
5,578
0.01% 675
2024
Q2
$258K Sell
5,578
-50
-0.9% -$2.3K 0.01% 640
2024
Q1
$267K Hold
5,628
0.01% 632
2023
Q4
$244K Hold
5,628
0.01% 630
2023
Q3
$213K Sell
5,628
-3,580
-39% -$141K 0.01% 669
2023
Q2
$347K Sell
9,208
-5,567
-38% -$205K 0.02% 546
2023
Q1
$552K Sell
14,775
-13
-0.1% -$549 0.03% 425
2022
Q4
$606K Buy
14,788
+1,616
+12% +$66.4K 0.04% 383
2022
Q3
$484K Buy
13,172
+347
+3% +$14.1K 0.03% 408
2022
Q2
$505K Buy
12,825
+1,274
+11% +$53.7K 0.02% 491
2022
Q1
$530K Buy
11,551
+1,609
+16% +$74.2K 0.02% 518
2021
Q4
$460K Sell
9,942
-1,004
-9% -$46.8K 0.02% 601
2021
Q3
$491K Sell
10,946
-321
-3% -$14.2K 0.02% 579
2021
Q2
$495K Sell
11,267
-111
-1% -$4.9K 0.02% 563
2021
Q1
$500K Buy
11,378
+444
+4% +$17.3K 0.01% 639
2020
Q4
$458K Buy
10,934
+910
+9% +$27.9K 0.02% 563
2020
Q3
$246K Buy
10,024
+7
+0.1% +$182 0.01% 616
2020
Q2
$244K Sell
10,017
-869
-8% -$20.8K 0.01% 605
2020
Q1
$234K Buy
10,886
+785
+8% +$23.5K 0.02% 562
2019
Q4
$337K Buy
10,101
+214
+2% +$6.96K 0.02% 533
2019
Q3
$314K Buy
9,887
+8,169
+475% +$258K 0.02% 516
2019
Q2
$54K Buy
1,718
+2
+0.1% +$62 ﹤0.01% 1145
2019
Q1
$51K Buy
1,716
+372
+28% +$11.1K ﹤0.01% 1124
2018
Q4
$36K Sell
1,344
-200
-13% -$5.91K ﹤0.01% 1246
2018
Q3
$49K Buy
1,544
+3
+0.2% +$97 ﹤0.01% 1180
2018
Q2
$48K Buy
1,541
+3
+0.2% +$95 ﹤0.01% 1069
2018
Q1
$47K Buy
1,538
+62
+4% +$1.96K ﹤0.01% 1021
2017
Q4
$46K Buy
1,476
+100
+7% +$3.06K ﹤0.01% 1036
2017
Q3
$40K Sell
1,376
-568
-29% -$16.5K ﹤0.01% 1061
2017
Q2
$55K Buy
1,944
+636
+49% +$17.7K 0.01% 882
2017
Q1
$36K Buy
1,308
+207
+19% +$5.75K ﹤0.01% 1014
2016
Q4
$29K Buy
1,101
+1
+0.1% +$26 ﹤0.01% 1032
2016
Q3
$26K Sell
1,100
-699
-39% -$16.8K ﹤0.01% 1033
2016
Q2
$41K Buy
1,799
+1
+0.1% +$23 0.01% 872
2016
Q1
$40K Buy
+1,798
New +$38.6K 0.01% 867

Other funds holding FXO

Geneos Wealth Management's FXO Position: Q2 2026 in Review

Geneos Wealth Management reduced its First Trust Financials AlphaDEX Fund (FXO) stake by 8.2% in Q2 2026, selling an estimated $78.6K and leaving 14,711 shares worth $919K. The position accounts for 0.02% of the portfolio, ranked #565.

Geneos Wealth Management first reported a position in FXO in Q1 2016 and has held it in 42 quarters since. 220 funds tracked by Wall St. Rank hold FXO as of Q2 2026.

  • Geneos Wealth Management held 14,711 shares of First Trust Financials AlphaDEX Fund worth $919K as of Q2 2026.
  • Geneos Wealth Management sold 1,320 First Trust Financials AlphaDEX Fund shares in Q2 2026, an estimated $78.6K.
  • First Trust Financials AlphaDEX Fund made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #565 holding.
  • Geneos Wealth Management first reported a position in First Trust Financials AlphaDEX Fund in Q1 2016 and has held it in 42 quarters since.
  • 220 funds tracked by Wall St. Rank held First Trust Financials AlphaDEX Fund as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.